Evidence map›Paper›PMID 32727512›Full record

ArticleSubstance abuse treatment, prevention, and policy2020

Investigating the sequential patterns of methamphetamine use initiation in Iran.

Ebrahim Moghimi Sarani, Jamshid Ahmadi, Bahare Oji, Motahareh Mahi-Birjand, Nader Bagheri, Amir Bazrafshan, Marie Dehghan Manshadi, Sajad Yaghoubi, Asiyeh Dezhkam, Mehrdad Khatami and 1 more

Open access · goldAbstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identifying the Factors Affecting Methamphetamine Use: A Scoping Review.Medical journal of the Islamic Republic of Iran · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Ebrahim Moghimi SaraniResearch Center for Psychiatry and Behavior Science, Shiraz university of Medical Sciences, Shiraz, Iran.
Jamshid AhmadiSubstance Abuse Research Center, Dual Diagnosis Ward, Shiraz University of Medical Sciences, Shiraz, Iran.
Bahare OjiDepartment of Psychiatry, Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Motahareh Mahi-BirjandInfectious Disease Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Nader BagheriCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Amir BazrafshanSubstance Abuse Research Center, Dual Diagnosis Ward, Shiraz University of Medical Sciences, Shiraz, Iran.
Marie Dehghan ManshadiDepartment of Humanistic Sciences, Islamic Azad University of Yazd, Yazd, Iran.
Sajad YaghoubiDepartment of Clinical Microbiology, Iranshahr University of Medical Sciences, Iranshahr, Iran.
Asiyeh DezhkamDepartment of Midwifery, School of Nursing and Midwifery, Iranshahr University of Medical Sciences, Iranshahr, Iran.
Mehrdad KhatamiNanoBioelectrochemistry Research Center, Bam University of Medical Sciences, Bam, Iran.
Meghdad Abdollahpour-AlitappehCellular and Molecular Biology Research Center, Larestan University of Medical Sciences, Larestan, 7431989335, Iran. Abdollahpour1983@yahoo.com.ORCID 0000-0002-5260-2527
Shiraz University of Medical Sciences · IRIranshahr University · IRBam University of Medical Sciences · IRBirjand University of Medical Sciences · IRIslamic Azad University, Larestan Branch · IRIslamic Azad University, Yazd · IRShahrekord University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMethamphetamine (MA) remains one of the most commonly used amphetamine-type stimulants, accounting for the second most widely-used substance after marijuana. Due to increased use of MA, a wide variety of research has focused on the patterns of MA use initiation among adolescents. Nevertheless, there are few data available for people who use MA. The present study set out to assess the sequential patterns of substance use initiation in patients with MA use disorders in Iran. MATERIALS AND

methodsThis cross-sectional study described substance initiation patterns for 302 patients who used MA admitted to hospitals and psychiatric centers of Shiraz University of Medical Sciences. The study was conducted between April 2015 and June 2016. After obtaining informed consents, participants were interviewed by trained interviewers using face-to-face, semi-structured interviews. The collecting data were analyzed using the chi square tests and one-way analysis of variance (ANOVA) tests to compare the relationship between qualitative and quantitative variables, respectively.

resultsOut of 302 participants enrolled in the study, 16 (5.3%) and 286 (94.7%) were female and male, respectively. The mean age of participants in the study was 37.29 years. The mean age of onset of MA use was found to be 15.9 years. 46.1% of the patients started MA use before 15 years. 77.2% of the patients who used MA had family members with a history of substance use. 93.71% of the patients who used MA started substance use with tobacco, alcohol, or opium, as the most frequent substances. Tobacco, as the first substance or starting substance, exhibited the most widely-used substance (69.53% of the cases). Tobacco-alcohol-cannabis-opium-heroin-MA sequencing was significantly related to the early onset of the substance use. Early-onset substance use was significantly higher in those with lower income, primary education, and family history of substance use. No significant relationship was found between employment status with the age of onset of substance use, and different substance use with marital status.

conclusionTobacco, alcohol and opium can be considered as the main sequencing substances for initiation to MA use. Standardized measures to decrease and control access to main starting and sequencing substances, including tobacco, alcohol, and opium, can greatly help decrease the early onset of the MA use, develop suitable prevention, and establish early intervention strategies.

Indexed as

AdolescentAdultAge of OnsetAmphetamine-Related DisordersCentral Nervous System StimulantsCross-Sectional StudiesFamilyFemaleHumansInterviews as TopicIranMaleMethamphetamineSocioeconomic FactorsSubstance-Related DisordersYoung AdultCentral Nervous System StimulantsMethamphetamineMethamphetamine (MA)Methamphetamine use initiationMethamphetamine use patternsSubstance sequences

Identifiers

PMID32727512
PMCPMC7392828
OpenAlexW3045669172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.